Inspire Medical Systems, Inc.INSPNYSE
LOADING
|||
R&D Expense Growth Under Pressure
Trending lower, below historical average.
Left:
||||
Year-over-year research & development expense growth
Latest
-7.62%
↓ 182% below average
Average (34q)
9.26%
Historical baseline
Range
High:44.44%
Low:-32.53%
Volatility
831.4%
High variability
| Period | Value |
|---|---|
| Q3 2025 | -7.62% |
| Q2 2025 | -5.73% |
| Q1 2025 | -8.35% |
| Q4 2024 | 16.31% |
| Q3 2024 | -9.62% |
| Q2 2024 | 0.03% |
| Q1 2024 | -7.09% |
| Q4 2023 | 6.55% |
| Q3 2023 | -5.44% |
| Q2 2023 | 20.78% |
| Q1 2023 | 20.10% |
| Q4 2022 | 1.21% |
| Q3 2022 | 44.44% |
| Q2 2022 | 22.44% |
| Q1 2022 | 15.31% |
| Q4 2021 | 7.07% |
| Q3 2021 | 3.51% |
| Q2 2021 | 13.91% |
| Q1 2021 | 11.93% |
| Q4 2020 | -0.30% |
| Q3 2020 | 20.54% |
| Q2 2020 | 11.47% |
| Q1 2020 | 44.36% |
| Q4 2019 | 3.97% |
| Q3 2019 | 27.30% |
| Q2 2019 | 9.34% |
| Q1 2019 | 20.96% |
| Q4 2018 | 21.51% |
| Q3 2018 | 2.07% |
| Q2 2018 | 0.29% |
| Q1 2018 | 2.85% |
| Q4 2017 | 43.03% |
| Q3 2017 | -32.53% |
| Q2 2017 | 9.42% |
| Q1 2017 | 0.00% |